Non-Hodgkin Lymphoma

Using HDAC3 Inhibitors to Reverse CREBBP Mutations in Lymphomas
January 13, 2020

This research could potentially pave the way for possible immunotherapy approaches for common forms of non-Hodgkin lymphoma.

CAR T-Cell Therapy Studies to Look for at the ASH Annual Meeting
November 27, 2019

Research on chimeric antigen receptor T-cell therapy to be presented at the ASH Annual Meeting & Exposition is set to address drawbacks associated with treatment.

Recent Research on Diabetes Mellitus, Non-Hodgkin Lymphoma Link
October 18, 2019

After conflicting opinions over the years, a study published in the journal Hematology explores the association between diabetes mellitus non-hodgkin lymphoma.